Patients' confidence in vaccines has waned since the COVID pandemic, according to a national poll and doctors.

Estimated effectiveness was 65% against hospitalization, 74% against pediatric intensive care unit admission, and 64% against ...

Dec. 23, 2024 — A year after becoming available, vaccines to protect against RSV in newborns and older adults are being more widely accepted by the American public, ... Scientists Design ...

Ask your parents or a caregiver if they have records from when you were a child. Call your past health-care providers. Some ...

Oct. 28, 2024 — Doctors detail what we learned after the first season following the approval of RSV vaccines. The vaccine effectively prevented severe illness in older, but only 24 percent of ...

This content summarizes current global health news, highlighting vaccine developments, disease outbreaks, and health ...

Respiratory syncytial virus (RSV) is a common cause of coughs and colds that can lead to more serious illness or cause baby death in the worst cases, say doctors. Infections usually get better by ...

GSK to showcase latest research at the International RSV Symposium to advance RSV prevention in adults: London, UK Saturday, March 8, 2025, 14:00 Hrs [IST] GSK plc will share its ...

we are delighted that the MHRA has authorized our RSV vaccine," said Darius Hughes, UK General Manager of Moderna. "With the MHRA decision, mRESVIA becomes Moderna's second approved product in the UK, ...

Three of the viruses — flu, COVID-19 and RSV — are respiratory viruses and spread from person to person through germ-filled ...